Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma

Journal of the National Cancer Institute
A PlatzU Ringborg

Abstract

Approximately 10% of human cutaneous melanomas occur in families in which several members are affected. The familial predisposition to this disease is often associated with dysplastic nevus syndrome, a condition in which afflicted family members have multiple dysplastic nevi (atypical moles). The chromosome region 9p21 and markers on chromosomes 1p and 6p have been linked to melanoma susceptibility. The tumor suppressor genes CDKN2A and CDKN2B have been mapped to the 9p21 region, and genetic analyses have revealed the presence of germline CDKN2A alterations in melanoma families. The reported frequencies of such alterations, however, vary among these families. The present investigation was carried out to determine the frequencies of CDKN2A and CDKN2B germline gene mutations among members in a population-based cohort of Swedish melanoma families (i.e., melanoma kindreds). DNA was prepared from blood samples obtained from 181 individuals belonging to 100 melanoma kindreds. The polymerase chain reaction (PCR) technique, followed by single-strand conformation polymorphism (SSCP) and nucleotide sequence analyses, were used to identify the types and frequencies of mutations in exons 1, 1beta, 2, and 3 of the CDKN2A gene and in exons 1...Continue Reading

References

Nov 13, 1992·Science·L A Cannon-AlbrightA E Bale
May 25, 1989·The New England Journal of Medicine·S J BaleM H Greene
Oct 12, 1995·The New England Journal of Medicine·A M GoldsteinW H Clark
Sep 1, 1994·Nature Genetics·C J HussussianN C Dracopoli
Dec 15, 1994·International Journal of Cancer. Journal International Du Cancer·G J WalkerN K Hayward
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·A LagerkvistU Landegren
Oct 1, 1995·Human Molecular Genetics·G J WalkerJ W Fountain

❮ Previous
Next ❯

Citations

Sep 25, 1999·International Journal of Cancer. Journal International Du Cancer·C WassbergU Ringborg
Nov 10, 2000·International Journal of Cancer. Journal International Du Cancer·P K MagnussonU B Gyllensten
Jul 31, 2001·Genes, Chromosomes & Cancer·P M PollockN K Hayward
Apr 30, 2002·International Journal of Cancer. Journal International Du Cancer·Kamila CzeneKari Hemminki
Dec 21, 2000·Current Oncology Reports·N Hayward
Feb 26, 1999·American Journal of Surgery·G J BullockP L Baron
Apr 4, 2000·Oral Oncology·M J Hicks, C M Flaitz
Jul 7, 2009·Nature Genetics·D Timothy BishopJulia A Newton Bishop
May 21, 1997·Journal of the National Cancer Institute·A M Goldstein, M A Tucker
Mar 10, 1999·Journal of the National Cancer Institute·J AitkenN Hayward
Jun 5, 2003·Journal of the National Cancer Institute·Malihe EskandarpourJohan Hansson
May 29, 2008·Journal of the National Cancer Institute·Daniel E FreedbergDavid Polsky
Sep 30, 2010·Journal of the National Cancer Institute·F DemenaisUNKNOWN Melanoma Genetics Consortium
Feb 27, 2001·Current Opinion in Oncology·S Halachmi, B A Gilchrest
Dec 17, 2008·Pigment Cell & Melanoma Research·Veronica HöiomJohan Hansson
Aug 15, 2006·Journal of Medical Genetics·Alisa M GoldsteinUNKNOWN Melanoma Genetics Consortium (GenoMEL)
Jan 8, 2008·Journal of Medical Genetics·A M GoldsteinK Stefansson
Jan 1, 2004·Hereditary Cancer in Clinical Practice·Tadeusz Debniak
Nov 7, 1998·Clinical Chemistry and Laboratory Medicine : CCLM·E A YakobsonH Peretz
Apr 17, 2012·Biochimica Et Biophysica Acta·Karin van den HurkVéronique J L Winnepenninckx
Aug 12, 1998·The Journal of Investigative Dermatology·R M MacKieJ M Connor
Sep 16, 2009·Journal of the American Academy of Dermatology·Sancy A LeachmanHensin Tsao
Jan 31, 2009·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Mia BergenmarYvonne Brandberg
Aug 24, 2007·The Journal of Investigative Dermatology·Patricia Ashton-ProllaDavid Hogg
Aug 21, 2001·The Journal of Investigative Dermatology·J WelchN K Hayward
Jan 25, 2003·The Journal of Investigative Dermatology·Kari HemminkiKamila Czene
Aug 13, 2010·The Journal of Investigative Dermatology·Anders JonssonSuzanne Egyhazi
Aug 2, 2008·The Surgical Clinics of North America·Johan Hansson
Dec 18, 2007·Seminars in Oncology·Julia A Newton Bishop, Nelleke A Gruis
Oct 7, 1997·Lancet·K Hemminki, P Vaittinen
May 7, 2015·International Journal of Cancer. Journal International Du Cancer·Hildur HelgadottirJohan Hansson
Aug 20, 2015·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Mariëtte E C WaaijerAndrea B Maier
Sep 1, 2000·Seminars in Cancer Biology·A PlatzJ Hansson
Jun 28, 2000·American Journal of Human Genetics·P CiottiA M Goldstein
Jul 5, 2003·American Journal of Human Genetics·Elizabeth GillandersUNKNOWN Melanoma Genetics Consortium
Apr 14, 2016·Genes, Chromosomes & Cancer·Rainer TuominenVeronica Höiom
Jun 18, 2014·Journal of Medical Genetics·Hildur HelgadottirJohan Hansson
Jun 12, 2016·Journal of the National Cancer Institute·Hildur HelgadottirJohan Hansson
Jul 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Johan HanssonInger Rosdahl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.